Making Lifestyle Changes Embracing a healthier lifestyle is essential when you start taking semaglutide
Preclinical and observational studies have suggested that GLP-1 receptor agonists, commonly used for weight loss and diabetes management, may also reduce alcohol intake
In the context of Retatrutide, the glucagon receptor activation shifts metabolic function toward increased energy expenditure and enhanced fat burning
The short version: gut points to oral, skin points to topical, and everything systemic points to injection
Planning your diet around the foods you tolerate at higher doses sets you up for better long-term adherence
Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in Tamalpais-Homestead Valley, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year